Company: BKYI
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001437749-25-021438
Chunk: 42

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 42
---
2025                                                                       |     |                |   247,837 |   |
| Total Equity Awards Outstanding(1)                                                                                                  |     |                |   249,694 |   |
| Common Stock Outstanding as of June 20, 2025                                                                                        |     |                | 6,848,775 |   |
| Current Dilution as of June 20, 2025(2)                                                                                             |     |                |       3.6 | % |
| Shares Remaining Available for Grant under the 2023 Plan as of June 20, 2025                                                        |     |                |    85,497 |   |
| Current Potential Dilution, or Overhang, Under the Amended Plan, as a Percentage of Common Stock Outstanding as of June 20, 2025(3) |     |                |       4.9 | % |
| Shares Available for Future Grant Under the Amended Plan                                                                            |     |                |   785,497 |   |
| Potential Dilution, or Overhang, Under the Amended Plan, as a Percentage of Common Stock Outstanding as of June 20, 2025 (4)        |     |                |      15.0 | % |

| (1) | Includes all awards outstanding under the 2015 plan and the 2023 plan. The only equity awards outstanding are stock options and restricted stock awards. No restricted stock units, performance stock units or other equity awards are outstanding. |

| (2) | Dilution consists of the number of shares subject to equity awards outstanding as of June 20, 2025 (249,694 shares) divided by the number of shares of common stock outstanding as of June 20, 2025 (6,848,775 shares). |

| (3) | Current potential dilution, or overhang, under our current equity plans consists of the number of shares subject to equity awards outstanding as of June 20, 2025 (249,694 shares) and the number of shares available for future grant under our current equity plans (85,497 shares) divided by the number of shares of common stock outstanding as of June 20, 2025 (6,848,775 shares). |

| (4) | Current potential dilution, or overhang, under the amended plan consists of the number of shares subject to equity awards outstanding as of June 20, 2025 (249,694 shares), the number of shares available for future grant under